首页|重视骨质疏松性骨折的早期干预

重视骨质疏松性骨折的早期干预

扫码查看
骨质疏松性骨折是一种特殊类型的病理性骨折,具有发病率高、致残率高、死亡率高和诊治率低的特点。目前,骨质疏松性骨折临床干预的主要问题在于医师(尤其是骨科医师)缺乏对疾病本身病理变化的正确认识。积极的手术治疗十分重要,但无法根本解决骨质疏松性骨折愈合迟缓和再骨折发生的严重后果,早期促成骨治疗可有效缩短骨折愈合时间,预防术后内植物移位,减少再骨折发生。本文强调积极面对骨质疏松性骨折的风险;正确认识骨质疏松性骨折的病理变化;全面重视骨质疏松性骨折的早期干预。
Pay attention to the early intervention of osteoporotic fractures
Osteoporotic fracture is a special type of pathological fracture characterized by high morbidity,high disability,high mortality and low diagnosis and treatment rate.Currently,the main problem with clinical intervention for osteoporotic fractures is the lack of proper understanding by doctors(especially orthopedic surgeons)of the pathologic changes in the disease itself.Aggressive surgical treatment is very important,but it cannot fundamentally solve the serious consequences of delayed healing of osteoporotic fractures and the occurrence of re-fractures.Early treatment by anabolic agents can effectively shorten the fracture healing time,prevent postoperative implants displacement,and reduce the occurrence of re-fractures.This article emphasizes the importance of actively facing the imminent risk of osteoporotic fracture;correctly recognizing the pathological changes of osteoporotic fracture;and comprehensively paying attention to the early intervention of osteoporotic fracture.

OsteoporosisOsteoporotic fractureBone anabolic agentsEarly treatment

林华、吕厚晨、唐佩福

展开 >

南京大学医学院附属鼓楼医院骨科,南京 210008

解放军总医院骨科医学部,北京 100853

骨质疏松 骨质疏松性骨折 促骨形成类药物 早期治疗

2025

中华医学杂志
中华医学会

中华医学杂志

北大核心
影响因子:1.477
ISSN:0376-2491
年,卷(期):2025.105(1)